Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 20Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Burkitt Lymphoma 8Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 4Lymphoma 4Leukemia, Myelomonocytic, Chronic 4Anemia, Refractory, with Excess of Blasts 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Myeloproliferative Disorders 3Leukemia, Biphenotypic, Acute 3Down Syndrome 3Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Anemia, Refractory 2Optic Nerve Glioma 1Neutropenia 1Neoplasm Metastasis 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Eosinophilic, Acute 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Cytarabine 6Daunorubicin 5Etoposide 3Observation 2Gemtuzumab 2Asparaginase 2valspodar 1palmitoyl-L-asparaginase 1midostaurin 1laromustine 1etoposide phosphate 1dexamethasone acetate 1aldesleukin 1Watchful Waiting 1Thioguanine 1Peripheral Blood Stem Cell Transplantation 1Mitoxantrone 1Interleukin-2 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Eosinophilic, Acute × Thioguanine × Clear all
NCT00369317 2022-01-28

Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic Syndromes

Children's Oncology Group

Phase 3 Completed
205 enrolled 19 charts
Other hematologic neoplasm

Leukemia, Eosinophilic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡